Kim Kelderman
2019
In 2019, Kim Kelderman earned a total compensation of $1.6M as President, Diagnostics and Genomics at Bio-Techne, a 34% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $304,796 |
|---|---|
| Option Awards | $600,028 |
| Salary | $452,400 |
| Stock Awards | $199,899 |
| Other | $8,250 |
| Total | $1,565,373 |
Kelderman received $600K in option awards, accounting for 38% of the total pay in 2019.
Kelderman also received $304.8K in non-equity incentive plan, $452.4K in salary, $199.9K in stock awards and $8.3K in other compensation.
Rankings
In 2019, Kim Kelderman's compensation ranked 7,123rd out of 13,971 executives tracked by ExecPay. In other words, Kelderman earned more than 49.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,123 out of 13,971 | 49th |
Division Manufacturing | 2,741 out of 5,692 | 52nd |
Major group Chemicals And Allied Products | 1,012 out of 2,189 | 54th |
Industry group Drugs | 857 out of 1,875 | 54th |
Industry Biological Products, Except Diagnostic Substances | 202 out of 389 | 48th |
Source: SEC filing on September 9, 2019.
Kelderman's colleagues
We found four more compensation records of executives who worked with Kim Kelderman at Bio-Techne in 2019.